129 related articles for article (PubMed ID: 34565623)
21. [A patient with Noonan syndrome].
Bins A; Gortzak RA
Ned Tijdschr Tandheelkd; 2013 Dec; 120(12):671-5. PubMed ID: 24555250
[TBL] [Abstract][Full Text] [Related]
22. Small bowel bezoar in a patient with Noonan syndrome: report of a case.
Bitton A; Keagle JN; Varma MG
MedGenMed; 2007 Feb; 9(1):34. PubMed ID: 17435641
[TBL] [Abstract][Full Text] [Related]
23. A case of Moyamoya disease in a girl with thyrotoxicosis.
Lee R; Sung K; Park YM; Yu JJ; Koh YC; Chung S
Yonsei Med J; 2009 Aug; 50(4):594-8. PubMed ID: 19718414
[TBL] [Abstract][Full Text] [Related]
24. Neurofibromatosis/Noonan phenotype: a variable feature of type 1 neurofibromatosis.
Colley A; Donnai D; Evans DG
Clin Genet; 1996 Feb; 49(2):59-64. PubMed ID: 8740913
[TBL] [Abstract][Full Text] [Related]
25. Myeloid disorders in infants with Noonan syndrome and a resident's "rule" recalled.
Side LE; Shannon KM
J Pediatr; 1997 Jun; 130(6):857-9. PubMed ID: 9202604
[No Abstract] [Full Text] [Related]
26. [A patient with features of the Noonan syndrome and neurofibromatosis].
de Planque MM; van der Graaff L; Meinders AE
Ned Tijdschr Geneeskd; 1983 Sep; 127(37):1674-8. PubMed ID: 6415498
[No Abstract] [Full Text] [Related]
27. Hypertrophic Cardiomyopathy in Noonan Syndrome Treated by MEK-Inhibition.
Andelfinger G; Marquis C; Raboisson MJ; Théoret Y; Waldmüller S; Wiegand G; Gelb BD; Zenker M; Delrue MA; Hofbeck M
J Am Coll Cardiol; 2019 May; 73(17):2237-2239. PubMed ID: 31047013
[No Abstract] [Full Text] [Related]
28. Childhood moyamoya disease accompanying Leigh syndrome.
Cullu N; Karakas E; Karakas O; Deveer M; Calik M; Boyaci FN
J Pak Med Assoc; 2013 Dec; 63(12):1538-40. PubMed ID: 24397103
[TBL] [Abstract][Full Text] [Related]
29. Clinical Characteristics of Moyamoya Angiopathy in a Pediatric Cohort.
Pines AR; Rodriguez D; Bendok BR; Dhamija R
J Child Neurol; 2020 May; 35(6):389-392. PubMed ID: 32089044
[TBL] [Abstract][Full Text] [Related]
30. Moyamoya syndrome or Behçet's disease?
Degirmenci E; Bir LS; Yagcı B; Nazliel B; Siva A
Int J Rheum Dis; 2014 Nov; 17(8):920-2. PubMed ID: 25307898
[No Abstract] [Full Text] [Related]
31. Revascularization of Moyamoya Angiopathy in Older Adults.
Williamson RW; Abla AA; Zabramski JM; Nakaji P; Spetzler RF; Wanebo JE
World Neurosurg; 2017 Mar; 99():37-40. PubMed ID: 27890765
[TBL] [Abstract][Full Text] [Related]
32. A neonate diagnosed with Noonan syndrome with myeloproliferative change.
Nagatomo K; Fukushima H; Kanai Y; Muramatsu H; Takada H
Pediatr Int; 2021 Dec; 63(12):1521-1523. PubMed ID: 34355465
[No Abstract] [Full Text] [Related]
33. Diabetes mellitus and the Moyamoya syndrome.
Bower RS; Mallory GW; Nwojo M; Meyer FB; Kudva YC
Ann Intern Med; 2012 Sep; 157(5):387-8. PubMed ID: 22944884
[No Abstract] [Full Text] [Related]
34. Moyamoya syndrome in a patient with Down syndrome presenting with chorea.
Takanashi J; Sugita K; Honda A; Niimi H
Pediatr Neurol; 1993; 9(5):396-8. PubMed ID: 8292217
[TBL] [Abstract][Full Text] [Related]
35. Cerebral occlusive artery disease in Noonan syndrome.
Wilms H; Neubauer B; Deuschl G; Zunker P
Cerebrovasc Dis; 2002; 14(2):133-5. PubMed ID: 12187019
[TBL] [Abstract][Full Text] [Related]
36. Noonan syndrome: a clinical and genetic study of 31 patients.
Bertola DR; Sugayama SM; Albano LM; Kim CA; Gonzalez CH
Rev Hosp Clin Fac Med Sao Paulo; 1999; 54(5):147-50. PubMed ID: 10788835
[TBL] [Abstract][Full Text] [Related]
37. [Noonan syndrome: a case report and literature review].
Chen J; Yang Y; Tan Z; Wang Y; Tang X; Gong Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Dec; 34(12):1261-5. PubMed ID: 20045924
[No Abstract] [Full Text] [Related]
38. Proximal left coronary artery occlusion in a 15-year-old boy with noonan syndrome and hypertrophic cardiomyopathy.
Delhaas T; Mühler EG
Pediatr Cardiol; 2003; 24(1):67-9. PubMed ID: 12574982
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous manifestations in Moyamoya angiopathy: A review.
Mitri F; Bersano A; Hervé D; Kraemer M
Eur J Neurol; 2021 May; 28(5):1784-1793. PubMed ID: 33486780
[TBL] [Abstract][Full Text] [Related]
40. Noonan syndrome-associated myeloproliferative disorder with somatically acquired monosomy 7: impact on clinical decision making.
Hofmans M; Schröder R; Lammens T; Flotho C; Niemeyer C; Van Roy N; Decaluwe W; Philippé J; De Moerloose B
Br J Haematol; 2019 Nov; 187(4):E83-E86. PubMed ID: 31617209
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
